BT
The startup utilizes Catalent's Zydis technology, a freeze-dried wafer that provides rapid dispersion rates for orally dissolving tablets. This approach enhances patient compliance and therapeutic outcomes by improving the ease of medication administration and overall quality of life.
Updated 2 months ago
Funding
$3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup utilizes Catalent's Zydis technology, a freeze-dried wafer that provides rapid dispersion rates for orally dissolving tablets. This approach enhances patient compliance and therapeutic outcomes by improving the ease of medication administration and overall quality of life.